Equine blood as a pre-screening model for the assessment of thrombogenicity of magnetic nanoparticles
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Characterization and Applications of Magnetic Nanoparticles · Protein Interaction Studies and Fluorescence Analysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. 9 - magnetic nanoparticles as contrast agents in magnetic resonance imaging and radiosensitizers in radiotherapy
2. Advances in engineering nanoparticles for magnetic particle imaging (MPI)
3. Magnetic nanoparticles in targeted drug delivery: a review10.1007/s10948-021-05932-9 ↗
4. Multiparametric modulation of magnetic transduction for biomolecular sensing in liquids10.1039/D3NR06489A ↗
5. Whither magnetic hyperthermia? A tentative roadmap
6. TPA immobilization on Iron oxide Nanocubes and localized magnetic hyperthermia accelerate blood clot lysis10.1002/adfm.201404354 ↗
7. Clot-targeted magnetic hyperthermia permeabilizes blood clots to make them more susceptible to thrombolysis10.1111/jth.15846 ↗
8. Preclinical and first-in-human safety studies on a novel magnetism-based haemofiltration method10.1038/s41598-024-64379-9 ↗
9. Magnetic coagulometry: towards a new nanotechnological tool for ex vivo monitoring coagulation in human whole blood10.1039/D3NR02593D ↗
10. Nanoparticles and the blood coagulation system. Part II: safety concerns10.2217/nnm.13.49 ↗
11. Action of nanoparticles on platelet activation and plasmatic coagulation10.2174/0929867323666160106151428 ↗
12. Controlling human platelet activation with calcium-binding nanoparticles10.1007/s12274-020-2912-8 ↗
13. International Organization for Standardization · 2025
14. International Conference on Harmonisation · 2010 · 3471
15. International Conference on Harmonisation · 2009
16. A multistep in vitro hemocompatibility testing protocol recapitulating the foreign body reaction to nanocarriers10.1007/s13346-022-01141-6 ↗
17. Positive selection during the evolution of the blood coagulation factors in the context of their disease-causing mutations10.1093/molbev/msu248 ↗
18. Equine hemostasis: description, evaluation, and alteration10.1016/S0749-0739(17)30660-0 ↗
19. Genetics of equine bleeding disorders10.1111/evj.13290 ↗
20. Comparison and simulation of different levels of erythrocyte aggregation with pig, horse, sheep, calf, and normal human blood
21. A comparative study of blood rheology across species10.1039/D1SM00258A ↗
22. Comparison of platelet number, mean platelet volume and platelet mass in five mammalian species, comparative Haematology
23. Viscoelasticity and structure of blood clots generated in-vitro by rheometry: a comparison between human, horse, rat, and camel10.3233/CH-189203 ↗
24. Jugular thrombophlebitis in horses: a review of fibrinolysis, thrombus formation, and clinical management
25. Fast synthesis of biocompatible iron oxide nanoparticles via a microwave-assisted Schikorr reaction: phase-director influence of iron glycinate complexes10.1016/j.jallcom.2025.181720 ↗
26. In situ measurement of magnetization relaxation of internalized nanoparticles in live cells10.1021/nn503888j ↗
27. The cellular magnetic response and biocompatibility of biogenic zinc- and cobalt-doped magnetite nanoparticles10.1038/srep39922 ↗
28. Dynamical magnetic response of Iron oxide nanoparticles inside live cells10.1021/acsnano.7b08995 ↗
29. First-principles calculations of magnetite (Fe3O4) above the Verwey temperature by using self-consistent DFT + U + V10.1021/acs.jctc.3c00860 ↗
30. Unraveling viscosity effects on the hysteresis losses of magnetic nanocubes10.1039/C7NR00810D ↗
31. The dynamics of thrombin formation10.1161/01.ATV.0000046238.23903.FC ↗
32. Influence of nanoparticles on the haemostatic balance: between thrombosis and haemorrhage, biomaterials
33. BSA-coated magnetic nanoparticles for improved therapeutic properties10.1039/C5TB00833F ↗
34. Effects of inter- and intra-aggregate magnetic dipolar interactions on the magnetic heating efficiency of iron oxide nanoparticles10.1039/C6CP00468G ↗
35. Dipolar interaction and demagnetizing effects in magnetic nanoparticle dispersions: introducing the mean-field interacting superparamagnet model10.1103/PhysRevB.95.134421 ↗
36. The role of dipole interactions in hyperthermia heating colloidal clusters of densely-packed superparamagnetic nanoparticles10.1038/s41598-018-23225-5 ↗
37. Mild magnetic hyperthermia is synergistic with an antibiotic treatment against dual species biofilms consisting of S. Aureus and P. Aeruginosa by enhancing metabolic activity10.1080/02656736.2023.2226845 ↗
38. Localized brain stimulation with mild magnetic hyperthermia promotes microglia activity towards reactive and autophagic phenotypes in vivo10.1038/s41598-025-10441-z ↗
39. Mild magnetic hyperthermia-activated immuno-responses for primary bladder cancer therapy10.1016/j.biomaterials.2024.122514 ↗
40. Multifunctionalized iron oxide nanoparticles for selective drug delivery to CD44-positive cancer cells10.1088/0957-4484/27/6/065103 ↗
41. Principles and practice of Thromboelastography in clinical coagulation management and transfusion practice10.1016/j.tmrv.2011.07.005 ↗
42. A review: hemocompatibility of magnetic nanoparticles and their regenerative medicine, cancer therapy, drug delivery, and bioimaging applications